Article
Screening for von Hippel-Lindau Disease by DNA Polymorphism Analysis
4 Mar 1992
Abstract excerpt
OBJECTIVE: Von Hippel-Lindau (VHL) disease is a rare, inherited multisystem neoplastic disorder. There is no biochemical test available to distinguish VHL disease gene carriers from their healthy siblings. We evaluated DNA polymorphism analysis as a method for identifying disease gene carriers. DESIGN: Prospective comparison of the results of DNA analysis with a comprehensive clinical screening examination....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
